| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.4 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |